View Older Stories View More Recent Stories
-
B&G Foods Reports Increases in Net Sales, Net Income and Adjusted EBITDA for Third Quarter 2015
-
A-dec Leads U.S. Dental Treatment Center Market Despite Increased Government Regulations
-
Groupe SEB: Nine-Month 2015 Sales and Financial Data
-
Widespread Gains in Home Prices for August According to the S&P/Case-Shiller Home Price Indices
-
Calgon Carbon Third Quarter 2015 Results Conference Call
-
Caterpillar Convenes Thought Leaders on Degraded Lands Restoration
-
UPS profit tops estimates as dollar weighs on revenue
-
Franklin Electric Reports Third Quarter 2015 Sales and Earnings
-
Franklin Electric Reports Third Quarter 2015 Sales and Earnings
-
Airgas Reports Fiscal 2016 Second Quarter Earnings
-
Waste Management Announces Third Quarter Earnings
-
Top U.S. drugmakers ride new products to strong results
-
CONSOL Energy Reports Third Quarter Results; Net Income of $119 million, or $0.52 per Diluted Share; 2015 E&P Production Guidance Increased to 325 - 330 Bcfe; Multi-Year Sales Secured to Bring Pen
-
United Therapeutics Corporation Reports Third Quarter 2015 Financial Results
-
M.D.C. Holdings Announces 2015 Third Quarter Results
-
Air Liquide: 3rd Quarter 2015: Sustained Sales Growth: +7.8%
-
Avcorp Signs Production Contract with Boeing
-
The Hartford Reports Third Quarter 2015 Net Income Of $0.90 Per Diluted Share And Core Earnings Of $0.86 Per Diluted Share
-
Waste Connections Reports Preliminary Third Quarter 2015 Results
-
John B. Sanfilippo & Son, Inc. First Quarter EPS Increased by 34% to a First Quarter Record $0.71 per Share Diluted
-
Allison Transmission Announces Third Quarter 2015 Results
-
American Capital Agency Corp. Reports $(0.43) Comprehensive Loss Per Common Share And $23.00 Net Book Value Per Common Share
-
Glancy Prongay & Murray LLP Announces the Filing of a Securities Class Action on Behalf of Valeant Pharmaceuticals International, Inc. Investors
-
Freddie Mac October 2015 Insight & Outlook
-
Technomic's Take: 2016 Food Trends
-
Drugmaker Valeant raises detailed defense but doubts remain
-
EZchip Files Supplement to Proxy Statement and Mails Letter to Shareholders
-
The Clorox Company Becomes Signatory to United Nations Global Compact
-
Valeant stock rebounds, but allegations shrink CEO's fortune
-
Fitch Affirms Tiffany's IDR at 'A-'; Outlook Stable
-
Shire Announces Third Quarter Earnings and Reiterates Full Year Guidance
-
Calgon Carbon Corporation Announces New Senior Leadership Appointments and Operating Divisions - Effective January 1
-
Royal Caribbean Reports Strong Third Quarter Results, Announces Share Repurchase Program And Takes A Non-Cash Write Down On Pullmantur
-
Procter & Gamble (PG) Tops Q1 EPS by 2c
-
P&G Delivers Double-Digit Currency-Neutral Core Earnings Per Share Growth in First Quarter Fiscal 2016; First Quarter Core EPS $0.98, Currency-Neutral Core EPS +12%; Core Operating Profit Margin u
-
Whirlpool Corporation Reports Third-Quarter Results
-
Electrolux: President and CEO Keith McLoughlin’s Comments on the Results for the Third Quarter 2015
-
Dechra® Pharmaceuticals PLC: Trading Update
-
Valeant's looming M&A hiatus deals blow to investment banks
-
Exclusive: BOJ to cut price forecast for next FY only slightly - sources
-
Celanese Corporation Declares Quarterly Dividend of $0.30 Per Share
-
Encore Wire Reports Third Quarter Results
-
Miami Single-Family Home Sales, Prices Rise in September
-
TRLPC: Valeant’s falling secondary loan price pulls pharma companies down
-
S&P Downgrades Mead Johnson (MJN) to 'BBB'; Notes Less Conservative Financial Policy
-
Valeant shares continue slide since Citron report
-
Valeant vows to refute 'phantom sales' allegations
-
Depomed (DEPO) Comments on Negative Horizon Pharma (HZNP) News; Had Speculated About Business Model
-
Depomed Comments on Recent Reports Regarding Horizon Pharma's Business Model
-
Deluxe Reports Third Quarter 2015 Financial Results

